TRC8-dependent degradation of hepatitis C virus immature core protein regulates viral propagation and pathogenesis

Signal-peptide peptidase (SPP) is an intramembrane protease that participates in the production of the mature core protein of hepatitis C virus (HCV). Here we show that SPP inhibition reduces the production of infectious HCV particles and pathogenesis. The immature core protein produced in SPP-knockout cells or by treatment with an SPP inhibitor is quickly degraded by the ubiquitin–proteasome pathway. Oral administration of the SPP inhibitor to transgenic mice expressing HCV core protein (CoreTg) reduces the expression of core protein and ameliorates insulin resistance and liver steatosis. Moreover, the haploinsufficiency of SPP in CoreTg has similar effects. TRC8, an E3 ubiquitin ligase, is required for the degradation of the immature core protein. The expression of the HCV core protein alters endoplasmic reticulum (ER) distribution and induces ER stress in SPP/TRC8 double-knockout cells. These data suggest that HCV utilizes SPP cleavage to circumvent the induction of ER stress in host cells.

[1]  Keiji Tanaka,et al.  Proteasome activator PA28gamma-dependent nuclear retention and degradation of hepatitis C virus core protein. , 2003, Journal of virology.

[2]  T. Tomita.  Molecular mechanism of intramembrane proteolysis by γ-secretase. , 2014, Journal of biochemistry.

[3]  M. Brown,et al.  A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[4]  S. Bloor,et al.  Cleavage by signal peptide peptidase is required for the degradation of selected tail-anchored proteins , 2014, The Journal of cell biology.

[5]  K. Mori,et al.  XBP1: a link between the unfolded protein response, lipid biosynthesis, and biogenesis of the endoplasmic reticulum. , 2004, The Journal of cell biology.

[6]  K. Ishii,et al.  Characterization of pseudotype VSV possessing HCV envelope proteins. , 2001, Virology.

[7]  Ralf Bartenschlager,et al.  The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection , 2013, Nature Reviews Microbiology.

[8]  K. Mori,et al.  The Sterol-sensing Endoplasmic Reticulum (ER) Membrane Protein TRC8 Hampers ER to Golgi Transport of Sterol Regulatory Element-binding Protein-2 (SREBP-2)/SREBP Cleavage-activated Protein and Reduces SREBP-2 Cleavage* , 2009, The Journal of Biological Chemistry.

[9]  G. Higgins,et al.  Chronic treatment with the gamma-secretase inhibitor LY-411,575 inhibits beta-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiation. , 2004, The Journal of biological chemistry.

[10]  R. Bartenschlager,et al.  The lipid droplet is an important organelle for hepatitis C virus production , 2007, Nature Cell Biology.

[11]  E. Siemers,et al.  A phase 3 trial of semagacestat for treatment of Alzheimer's disease. , 2013, The New England journal of medicine.

[12]  J. McLauchlan,et al.  Intramembrane proteolysis promotes trafficking of hepatitis C virus core protein to lipid droplets , 2002, The EMBO journal.

[13]  H. Langen,et al.  Hepatitis C virus core protein: carboxy-terminal boundaries of two processed species suggest cleavage by a signal peptide peptidase. , 1996, Virology.

[14]  F. Li,et al.  The hereditary renal cell carcinoma 3;8 translocation fuses FHIT to a patched-related gene, TRC8. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[15]  D. Langosch,et al.  Signal peptide peptidase functions in ERAD to cleave the unfolded protein response regulator XBP1u , 2014, The EMBO journal.

[16]  W. Kamitani,et al.  Heterogeneous Nuclear Ribonucleoprotein A2 Participates in the Replication of Japanese Encephalitis Virus through an Interaction with Viral Proteins and RNA , 2011, Journal of Virology.

[17]  Chris Sander,et al.  Cellular cofactors affecting hepatitis C virus infection and replication , 2007, Proceedings of the National Academy of Sciences.

[18]  S. Romeo,et al.  Hepatocellular carcinoma in nonalcoholic fatty liver: role of environmental and genetic factors. , 2014, World journal of gastroenterology.

[19]  K Koike,et al.  Hepatitis C virus core protein induces hepatic steatosis in transgenic mice. , 1997, The Journal of general virology.

[20]  M. Mizokami,et al.  Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon. , 2003, Gastroenterology.

[21]  J. Corradi,et al.  Signal Peptide Peptidase and γ-Secretase Share Equivalent Inhibitor Binding Pharmacology* , 2007, Journal of Biological Chemistry.

[22]  K. Ishii,et al.  Oligomerization of Hepatitis C Virus Core Protein Is Crucial for Interaction with the Cytoplasmic Domain of E1 Envelope Protein , 2006, Journal of Virology.

[23]  Charles M. Rice,et al.  The ins and outs of hepatitis C virus entry and assembly , 2013, Nature Reviews Microbiology.

[24]  S. Boulant,et al.  Maturation of Hepatitis C Virus Core Protein by Signal Peptide Peptidase Is Required for Virus Production* , 2008, Journal of Biological Chemistry.

[25]  Yoshitaka Fujihara,et al.  Generation of mutant mice by pronuclear injection of circular plasmid expressing Cas9 and single guided RNA , 2013, Scientific Reports.

[26]  G. Chae,et al.  Palmitate induces cisternal ER expansion via the activation of XBP-1/CCTα-mediated phospholipid accumulation in RAW 264.7 cells , 2015, Lipids in Health and Disease.

[27]  Keiji Tanaka,et al.  Critical role of PA28γ in hepatitis C virus-associated steatogenesis and hepatocarcinogenesis , 2007, Proceedings of the National Academy of Sciences.

[28]  Y. Matsuura,et al.  Hepatitis C virus core protein: its coordinate roles with PA28gamma in metabolic abnormality and carcinogenicity in the liver. , 2008, The international journal of biochemistry & cell biology.

[29]  Mair E. M. Thomas,et al.  The TRC8 E3 ligase ubiquitinates MHC class I molecules before dislocation from the ER , 2009, The Journal of cell biology.

[30]  A. Schmitz,et al.  Targeting Presenilin-type Aspartic Protease Signal Peptide Peptidase with γ-Secretase Inhibitors* , 2003, The Journal of Biological Chemistry.

[31]  Yoshiharu Matsuura,et al.  The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice , 1998, Nature Medicine.

[32]  K. Koike,et al.  Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance. , 2004, Gastroenterology.

[33]  E. Konishi,et al.  Nuclear Localization of Japanese Encephalitis Virus Core Protein Enhances Viral Replication , 2005, Journal of Virology.

[34]  B. Martoglio,et al.  Requirements for signal peptide peptidase-catalyzed intramembrane proteolysis. , 2002, Molecular cell.

[35]  J. Dubuisson,et al.  Glycosylation of the Hepatitis C Virus Envelope Protein E1 Is Dependent on the Presence of a Downstream Sequence on the Viral Polyprotein* , 2000, The Journal of Biological Chemistry.

[36]  Jay S. Fine,et al.  Chronic Treatment with the γ-Secretase Inhibitor LY-411,575 Inhibits β-Amyloid Peptide Production and Alters Lymphopoiesis and Intestinal Cell Differentiation* , 2004, Journal of Biological Chemistry.

[37]  S. Fang,et al.  RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[38]  N. Enomoto,et al.  Hallmarks of Hepatitis C Virus in Equine Hepacivirus , 2014, Journal of Virology.

[39]  M. Ikawa,et al.  CRISPR/Cas9-based genome editing in mice by single plasmid injection. , 2014, Methods in enzymology.

[40]  H. Niwa,et al.  Efficient selection for high-expression transfectants with a novel eukaryotic vector. , 1991, Gene.

[41]  T. Wakita,et al.  Characterization of the E-138 (Glu/Lys) mutation in Japanese encephalitis virus by using a stable, full-length, infectious cDNA clone. , 2005, The Journal of general virology.

[42]  M. Takeda,et al.  Intramembrane Processing by Signal Peptide Peptidase Regulates the Membrane Localization of Hepatitis C Virus Core Protein and Viral Propagation , 2008, Journal of Virology.

[43]  B. Martoglio,et al.  Identification of Signal Peptide Peptidase, a Presenilin-Type Aspartic Protease , 2002, Science.

[44]  Y. Jo,et al.  Sterol-induced degradation of HMG CoA reductase depends on interplay of two Insigs and two ubiquitin ligases, gp78 and Trc8 , 2011, Proceedings of the National Academy of Sciences.

[45]  P. Howley,et al.  E6AP Ubiquitin Ligase Mediates Ubiquitylation and Degradation of Hepatitis C Virus Core Protein , 2006, Journal of Virology.

[46]  Yamamura Ken-ichi,et al.  Efficient selection for high-expression transfectants with a novel eukaryotic vector , 1991 .

[47]  S. Emerson,et al.  Advantages of a single-cycle production assay to study cell culture-adaptive mutations of hepatitis C virus , 2008, Proceedings of the National Academy of Sciences.

[48]  K. Ahn,et al.  Protein disulphide isomerase is required for signal peptide peptidase‐mediated protein degradation , 2010, The EMBO journal.

[49]  Y. Matsuura,et al.  Intramembrane Proteolysis and Endoplasmic Reticulum Retention of Hepatitis C Virus Core Protein , 2004, Journal of Virology.

[50]  Keiji Tanaka,et al.  Proteasome Activator PA28γ-Dependent Nuclear Retention and Degradation of Hepatitis C Virus Core Protein , 2003, Journal of Virology.

[51]  T. Asselah,et al.  In vivo hepatic endoplasmic reticulum stress in patients with chronic hepatitis C , 2010, The Journal of pathology.

[52]  J. Goldstein,et al.  Differential Stimulation of Cholesterol and Unsaturated Fatty Acid Biosynthesis in Cells Expressing Individual Nuclear Sterol Regulatory Element-binding Proteins* , 1998, The Journal of Biological Chemistry.

[53]  K. Ishii,et al.  Proteasomal Turnover of Hepatitis C Virus Core Protein Is Regulated by Two Distinct Mechanisms: a Ubiquitin-Dependent Mechanism and a Ubiquitin-Independent but PA28γ-Dependent Mechanism , 2008, Journal of Virology.

[54]  H. Ploegh,et al.  Signal peptide peptidase is required for dislocation from the endoplasmic reticulum , 2006, Nature.

[55]  A. Schmitz,et al.  Targeting presenilin-type aspartic protease signal peptide peptidase with gamma-secretase inhibitors. , 2003, The Journal of biological chemistry.

[56]  L. Staudt,et al.  XBP1, downstream of Blimp-1, expands the secretory apparatus and other organelles, and increases protein synthesis in plasma cell differentiation. , 2004, Immunity.

[57]  C. Lai,et al.  Genetic determinants of dengue type 4 virus neurovirulence for mice , 1993, Journal of virology.

[58]  R. Bartenschlager,et al.  Production of infectious hepatitis C virus in tissue culture from a cloned viral genome , 2005, Nature Medicine.

[59]  L. Chau,et al.  TRC8 suppresses tumorigenesis through targeting heme oxygenase-1 for ubiquitination and degradation , 2013, Oncogene.

[60]  J. Silver,et al.  Replication of Subgenomic Hepatitis C Virus Rnas in a Hepatoma Cell Line , 1999 .

[61]  A. Nomoto,et al.  Membrane Binding Properties and Terminal Residues of the Mature Hepatitis C Virus Capsid Protein in Insect Cells , 2004, Journal of Virology.

[62]  R. Hammer,et al.  Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2. , 1998, The Journal of clinical investigation.